CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
Clinical trial NCT02965092 · UNKNOWN
Trial details
- NCT number
- NCT02965092
- Sponsor
- Wuhan Sian Medical Technology Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-02
- Primary completion
- 2021-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.